Noetic Fund is a Toronto-based venture capital firm focused on mental health, CNS disorders, and wellness-related innovation. It typically invests at seed through Series A and is built around a thesis-led approach informed by scientific and entrepreneurial expertise. The fund sits at the intersection of mental health, neurotechnology, and emerging therapeutic modalities.

Its investment approach prioritizes evidence-based solutions across biotech, devices, and digital health, with particular interest in CNS and neuropsychiatric problems. That gives it stronger thematic alignment with brain and mental health than many generalist healthcare funds. It is most relevant where neurotechnology overlaps with mental health treatment, measurement, or therapeutic development.

Noetic invests globally, with strongest activity in North America and Europe. For neurotech founders, it is an important specialist target for companies working in CNS, precision psychiatry, mental health devices, or adjacent digital therapeutics. Its value lies in thematic fit and domain depth rather than sheer scale.